|
|
||||||||
The following is the abstract of the article discussed in the subsequent letter:
| |
ABSTRACT |
|---|
Perhonen, Merja A., Fatima Franco, Lynda D. Lane, Jay C. Buckey, C. Gunnar Blomqvist, Joseph E. Zerwekh, Ronald M. Peshock, Paul T. Weatherall, and Benjamin D. Levine. Cardiac atrophy after bed rest and spaceflight. J Appl
Physiol 91: 645-653, 2001.
Cardiac muscle adapts well to
changes in loading conditions. For example, left ventricular (LV)
hypertrophy may be induced physiologically (via exercise training) or
pathologically (via hypertension or valvular heart disease). If
hypertension is treated, LV hypertrophy regresses, suggesting a
sensitivity to LV work. However, whether physical inactivity in
nonathletic populations causes adaptive changes in LV mass or even
frank atrophy is not clear. We exposed previously sedentary men to 6 (n = 5) and 12 (n = 3) wk of horizontal bed rest. LV and right ventricular (RV) mass and end-diastolic volume
were measured using cine magnetic resonance imaging (MRI) at 2, 6, and
12 wk of bed rest; five healthy men were also studied before and after
at least 6 wk of routine daily activities as controls. In addition,
four astronauts were exposed to the complete elimination of hydrostatic
gradients during a spaceflight of 10 days. During bed rest, LV mass
decreased by 8.0 ± 2.2% (P = 0.005) after 6 wk
with an additional atrophy of 7.6 ± 2.3% in the subjects who
remained in bed for 12 wk; there was no change in LV mass for the
control subjects (153.0 ± 12.2 vs. 153.4 ± 12.1 g,
P = 0.81). Mean wall thickness decreased (4 ± 2.5%, P = 0.01) after 6 wk of bed rest associated with
the decrease in LV mass, suggesting a physiological remodeling with
respect to altered load. LV end-diastolic volume decreased by 14 ± 1.7% (P = 0.002) after 2 wk of bed rest and changed
minimally thereafter. After 6 wk of bed rest, RV free wall mass
decreased by 10 ± 2.7% (P = 0.06) and RV
end-diastolic volume by 16 ± 7.9% (P = 0.06).
After spaceflight, LV mass decreased by 12 ± 6.9%
(P = 0.07). In conclusion, cardiac atrophy occurs during prolonged (6 wk) horizontal bed rest and may also occur after
short-term spaceflight. We suggest that cardiac atrophy is due to a
physiological adaptation to reduced myocardial load and work in real or
simulated microgravity and demonstrates the plasticity of cardiac
muscle under different loading conditions.
| |
LETTER |
|---|
To the Editor: Perhonen and co-workers (4) report that existence in simulated and actual microgravity leads to cardiac atrophy. I thank the authors for their interesting, convincing, and important work. In their DISCUSSION, they speculate that chronic lack of cardiac distension in microgravity contributes to cardiac atrophy, as previously hypothesized (7). This idea raises the possibility of using nocturnal lower body positive pressure (LBPP) as a countermeasure against microgravity-induced cardiac atrophy.
Application of LBPP during sleep in microgravity could potentially reproduce the central fluid volume redistribution and cardiac distension experienced while recumbent for several hours per night on Earth. LBPP is a relatively benign and technically simple procedure, physiologically similar to head-out water immersion in 1 G (1). If lack of cardiac distension for several hours per night causes cardiac remodeling and reduced myocardial mass in chronic microgravity, then replacement via LBPP of this nightly cardiac distension may help prevent such myocardial atrophy.
Previous work demonstrates that central volume expansion at night does not elicit diuresis to the extent that similar volume expansion provokes during the day (e.g., Ref. 5). Therefore, nocturnal LBPP should not exacerbate microgravity-induced hypovolemia if nighttime antidiuresis operates during spaceflight similarly to Earth-bound circadian conditions.
In regard to microgravity-induced hypovolemia, from the discussion of Perhonen et al. (4) on diuresis during the first 24 h of bed rest, a reader could reasonably conclude that a similar renal response occurs during spaceflight. However, diuresis is not seen in flight; in fact, existing data suggest acute and chronic antidiuresis early in spaceflight (2, 3, 6). I respect that Perhonen et al. did not state that "spaceflight causes diuresis." However, because this is a widespread misconception, these differences between bed rest and spaceflight need to be explicitly recognized.
| |
REFERENCES |
|---|
1.
Geelen, G,
Kravik SE,
Hadj-Aissa A,
Leftheriotis G,
Vincent M,
Bizollon CA,
Sem-Jacobsen CW,
Greenleaf JE,
and
Gharib C.
Antigravity suit inflation: kidney function and cardiovascular and hormonal responses in men.
J Appl Physiol
66:
792-799,
1989
2.
Leach, CS,
Alfrey CP,
Suki WN,
Leonard JI,
Rambaut PC,
Inners LD,
Smith SM,
Lane HW,
and
Krauhs JM.
Regulation of body fluid compartments during short-term spaceflight.
J Appl Physiol
81:
105-116,
1996
3.
Norsk, P,
Drummer C,
Rocker L,
Strollo F,
Christensen NJ,
Warberg J,
Bie P,
Stadeager C,
Johansen LB,
Heer M,
Gunga HC,
and
Gerzer R.
Renal and endocrine responses in humans to isotonic saline infusion during microgravity.
J Appl Physiol
78:
2253-2259,
1995
4.
Perhonen, MA,
Franco F,
Lane LD,
Buckey JC,
Blomqvist CG,
Zerwekh JE,
Peshock RM,
Weatherall PT,
and
Levine BD.
Cardiac atrophy after bed rest and spaceflight.
J Appl Physiol
91:
645-653,
2001
5.
Shiraki, K,
Konda N,
Sagawa S,
Claybaugh JR,
and
Hong SK.
Cardiorenal-endocrine responses to head-out immersion at night.
J Appl Physiol
60:
176-183,
1986
6.
Watenpaugh, DE.
Fluid volume control during short-term space flight and implications for human performance.
J Exp Biol
204:
3209-3215,
2001
7.
Watenpaugh, DE,
and
Hargens AR.
The cardiovascular system in microgravity.
In: Handbook of Physiology. Environmental Physiology. Bethesda, MD: Am. Physiol. Soc, 1996, sect. 4, vol. I, chapt. 29, p. 631-674.
|
Donald E. Watenpaugh, Naval Submarine Medical Research Laboratory Box 900 Groton, Connecticut 06349-5900 E-mail: watenpaugh{at}nsmrl.navy.mil |
To the Editor: Dr. Watenpaugh presents an interesting
hypothesis, namely, that providing a positive pressure to the lower part of the body at night, also called LBPP, could stretch the heart
and minimize cardiac atrophy during exposure to microgravity. Pilot
work in our laboratory could not confirm a sustained increase in either
central venous pressure or stroke volume from LBPP, possibly due to
stress-relaxation of the venous capacitance vessels or even
translocation of blood past the heart into the head and neck.
Therefore, we have not been enthusiastic about applying this stimulus
as a tool to expand the heart during our experiments. However, the idea
certainly is intriguing, and we look forward to seeing such experiments
conducted by Dr. Watenpaugh or others.
Dr. Watenpaugh also rightly points out that a diuresis has not been
observed during early spaceflight, and we were careful not to state so
explicitly. However, as noted by Dr. Watenpaugh himself (2), much of
this failure may be due to the specific circumstances of flight
experiments and the specific body position to which the comparison is
being made. In space, the first measurements are usually not made until
after the astronauts have been lying for many hours with their feet up
in the air in the "prelaunch" position. Thus much of the short-term
diuresis and natriuresis that would normally occur with the transition
from standing upright in 1 G to microgravity has already occurred
before launch. Subsequent measurements are then affected by limited
fluid intake during the first few hours in space, in part because of
the development of space motion sickness and also because of reduced
access to fluids. Ultimately, it has been well documented that plasma
volume is reduced early during exposure to space flight (1), although it is not certain whether this reduction occurs in the kidney or in the
extravascular space. We agree with Dr. Watenpaugh's speculation (2)
that if an astronaut could be transported immediately from the upright
position on Earth to space then a diuresis would likely be observed, as
has been noted in virtually all ground-based models.
![]()
REPLY
| |
FOOTNOTES |
|---|
10.1152/japplphysiol.01016.2001
| |
REFERENCES |
|---|
1.
Leach, CS,
Alfrey CP,
Suki WN,
Leonard JI,
Rambaut PC,
Inners LD,
Smith SM,
Lane HW,
and
Krauhs JM.
Regulation of body fluid compartments during short-term spaceflight.
J Appl Physiol
81:
105-116,
1996.
2.
Watenpaugh, DE.
Fluid volume control during short-term space flight and implications for human performance.
J Exp Biol
204:
3209-3215,
2001.
|
Benjamin Levine, Institute for Exercise and Environmental Medicine Presbyterian Hospital of Dallas Dallas, Texas 75231-5129 E-mail: benjaminlevine{at}texashealth.org |
This article has been cited by other articles:
![]() |
M. V. Pancheva, V. S. Panchev, A. V. Suvandjieva, and B. D. Levine Lower body negative pressure vs. lower body positive pressure to prevent cardiac atrophy after bed rest and spaceflight. What caused the controversy? J Appl Physiol, March 1, 2006; 100(3): 1090 - 1090. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |